193 filings
Page 4 of 10
6-K
rlzjhzmz16s
10 Nov 20
Open Market Sale Agreementsm
8:21am
424B5
vuwgovoa9xvuynm
10 Nov 20
Prospectus supplement for primary offering
8:14am
6-K
h7txlxlu1rqx 11ucd
10 Nov 20
Current report (foreign)
6:33am
6-K
bwccplx o12xyv
9 Nov 20
Affimed and Roivant Sciences Announce Licensing and Strategic
4:31pm
6-K
9so8 vgmd77zkrm2g9c
11 Aug 20
Condensed Consolidated Financial Statements
6:32am
6-K
rgo8b3p
5 Aug 20
Current report (foreign)
7:00am
6-K
bfxpma92e4gbpy84
27 Jul 20
Current report (foreign)
4:36pm
6-K
0hnm3egebpdx56h0dq3
10 Jul 20
Affimed Announces Annual General Meeting of Shareholders
8:11am
6-K
nvtcb6q
23 Jun 20
Current report (foreign)
6:44am
6-K
a143jrw5d6a7g
13 May 20
Open Market Sale Agreementsm
4:32pm
424B5
5j6umw250o5 2n2utv
13 May 20
Prospectus supplement for primary offering
4:31pm
6-K
n9nxenwvn t8mi
28 Apr 20
Affimed Reports 2019 Financial Results and Recent Operational Progress
6:48am
6-K
m4x8e0
3 Feb 20
Current report (foreign)
7:38am
6-K
ise0ckf
19 Nov 19
Current report (foreign)
7:47am
6-K
l44n0
13 Nov 19
Current report (foreign)
5:18pm
424B5
i878lp9b1glpwndo7
12 Nov 19
Prospectus supplement for primary offering
4:13pm
6-K
wo10hz1df6fxh wpg
7 Nov 19
Affimed Announces Proposed Public Offering of Common Shares
5:11pm
424B5
f2g n8e5lr0uazds0
7 Nov 19
Prospectus supplement for primary offering
5:01pm
6-K
y0u19ynu thrufbj3
7 Aug 19
Condensed Consolidated Financial Statements
8:24am